Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

Frederik Neess Engsig; Jan Gerstoft; Gitte Kronborg; Carsten S Larsen; Anne M Audelin; Louise B Jørgensen; Niels Obel; Gitte Pedersen

Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

Frederik Neess Engsig, Jan Gerstoft, Gitte Kronborg, Carsten S Larsen, Anne M Audelin, Louise B Jørgensen, Niels Obel, Gitte Pedersen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

4 Citationer (Scopus)

Abstract

Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.

Originalsprog	Engelsk
Vol/bind	2
Sider (fra-til)	145-51
Antal sider	7
Status	Udgivet - 1 jan. 2010
Udgivet eksternt	Ja

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

@article{5c48115c229240ddb9952e974500343e,

title = "Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen",

abstract = "Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.",

author = "Engsig, {Frederik Neess} and Jan Gerstoft and Gitte Kronborg and Larsen, {Carsten S} and Audelin, {Anne M} and J{\o}rgensen, {Louise B} and Niels Obel and Gitte Pedersen",

year = "2010",

month = jan,

day = "1",

language = "English",

volume = "2",

pages = "145--51",

issn = "1878-5921",

publisher = "Elsevier",

}

TY - JOUR

T1 - Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

AU - Engsig, Frederik Neess

AU - Gerstoft, Jan

AU - Kronborg, Gitte

AU - Larsen, Carsten S

AU - Audelin, Anne M

AU - Jørgensen, Louise B

AU - Obel, Niels

AU - Pedersen, Gitte

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.

AB - Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.

M3 - Journal article

SN - 1878-5921

VL - 2

SP - 145

EP - 151

ER -

Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

Abstract

AUB Link

Fingeraftryk

Citationsformater